Sechenov School
Home › Pathology › Tumor Markers: Classification, Methods and Diagnostics

Tumor Markers

For medical students2 min readUpdated 2026-10-10

Tumor markers are specific molecular, genetic, or structural features that allow for the identification of neoplasms. They play a critical role in the diagnosis of poorly differentiated and undifferentiated malignant tumors when traditional morphology is insufficient.

Traditional approachEffective exclusively for differentiated tumors and their metastases
Molecular levelDetects genome and ultrastructural alterations in undifferentiated cells
ClassificationIncludes 6 main marker groups, ranging from cellular differentiation to apoptosis
Main goalPrecise tumor verification to select the appropriate treatment strategy

The Problem of Traditional Diagnostics

Traditional morphological research methods have remained and continue to be the baseline standard in oncopathology for decades. Their essence lies in the visual assessment of tissue and cellular architecture under a light microscope. This classical approach demonstrates high diagnostic value when dealing with differentiated tumors and their metastases. In such clinical cases, tumor cells sufficiently retain the characteristic features of the tissue from which they originally arose, allowing the pathologist to reliably determine the source of tumor growth.

However, in real-world clinical practice, specialists regularly encounter poorly differentiated and undifferentiated malignant tumors. During their development, the cells of these aggressive neoplasms lose their initial specialization to such an extent that visually establishing their tissue origin becomes entirely impossible. It is precisely in this complex diagnostic situation that modern molecular-biological and high-tech morphological methods come to the rescue. They allow physicians to look deep inside the cell—at the ultrastructural and molecular-genetic levels.

Modern Research Methods

An arsenal of advanced laboratory technologies is used to identify the specific characteristics of a tumor cell. Each of the methods listed below solves a narrow diagnostic task, and their well-chosen combination provides specialists with the most complete picture of the disease:

Classification of Tumor Markers

Depending on which pathological process, structural element, or cellular mechanism a specific marker reflects, modern pathology generally divides them into six main classification groups:

  1. Markers of cellular differentiation: Demonstrate which cell type the studied tumor is striving to resemble, even if it appears completely undifferentiated outwardly.
  2. Histo- and cytogenetic markers: Directly indicate the tissue origin of the malignant neoplasm, helping to determine the primary tumor site.
  3. Markers of chromosomal and gene rearrangements: Reflect the fundamental genetic mutations underlying the malignant transformation of the cell.
  4. Markers of altered cell proliferation: Demonstrate the rate and degree of aggressiveness of tumor cell division, which is critical for assessing disease prognosis.
  5. Markers of cell death (apoptosis): Allow physicians to assess how successfully tumor cells can evade programmed cell death.
  6. Markers of invasion and metastasis: Characterize the ability of malignant cells to destroy surrounding healthy tissues, penetrate blood vessels, and form secondary foci.

Mnemonic

To remember the 6 marker groups, use the phrase: "Differentiated Genetics Rearranges Proliferation, Apoptosis, and Metastasis" (Differentiation, Histo/cytogenetic, Rearrangements, Proliferation, Apoptosis, Metastasis).

Frequently asked questions

Which specific markers belong to the group of cellular differentiation markers?

Cellular differentiation markers mentioned in the sources include:

  • Neuronal markers — neuron-specific enolase, synaptophysin.
  • Chromogranin — a marker of neuroendocrine differentiation.
  • Hematopoietic cell markers — CD45 and other CD markers.
  • Muscle differentiation markers — myogenin, desmin, actin.
  • Mesenchymal differentiation marker — vimentin.
  • Marker of primitive neuroectodermal tumors — CD99.
  • S-100 protein — a marker of Schwann cell differentiation.
  • Pancytokeratins — expressed in small cell lung cancer.
Which marker proteins are used to assess cell death and apoptosis?

The sources indicate the following proteins involved in assessing cell death and apoptosis:

  • Initiator caspases — caspase 8 and caspase 9.
  • Executioner caspases — caspase 3, as well as caspases 6 and 7.
  • Adapter proteins — FADD and Apaf-1.
  • Pro-apoptotic proteins — p53, Bax, and Bak.
  • Anti-apoptotic protein — Bcl-2.
  • Targets of executioner caspases — Rb, PARP, and CAD.
  • CD107 (LAMP) — a marker of cytotoxic T-lymphocyte and NK cell degranulation.
What specific proliferation markers are used to assess the aggressiveness of tumor cell division?

To assess the proliferative activity of tumor cells, the Ki-67 marker protein is used, which is detected via immunohistochemistry. Mitotic counting (mitotic index) is also employed. In adrenocortical carcinoma, Ki-67 is indicated as a reliable negative prognostic indicator, while in breast cancer, the presence of Ki-67 defines a subgroup with high proliferative activity.

In what cases does traditional morphology fail in diagnostics?

Traditional methods lose their effectiveness when investigating poorly differentiated and undifferentiated malignant tumors, as their cells completely lose the features of the original tissue.

What methods are used to diagnose undifferentiated tumors?

Molecular biological and modern morphological methods (PCR, in situ hybridization, immunohistochemistry, electron microscopy) are used for such neoplasms to evaluate alterations at the ultrastructural and molecular-genetic levels.

What does in situ hybridization allow you to visualize?

This method allows the detection of specific nucleic acid sequences directly within a cell or tissue while preserving their natural spatial arrangement.

Go deeper

More topics in Pathology

Renal Tumors: Pathology and ClassificationHypersensitivity PneumonitisIschemic and Pseudomembranous ColitisPrimary Biliary CholangitisRabiesMyeloproliferative NeoplasmsPatent Ductus ArteriosusParasitic Diseases and Highly Dangerous InfectionsPorphyriasAbscessCystitisPulmonary SarcoidosisPathology →